CommentReal-world evidence in safety assessment of new treatments
References (8)
- et al.
Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study
Biol Blood Marrow Transplant
(2007) - et al.
Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies
Lancet Haematol
(2018) - et al.
Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment
Hematology Am Soc Hematol Educ Program
(2016) - et al.
Outcome and survival of myeloma patients diagnosed 2008–2015. Real-world data on 4904 patients from the Swedish Myeloma Registry
Haematologica
(2018)
There are more references available in the full text version of this article.
Cited by (0)
© 2018 Elsevier Ltd. All rights reserved.